Anti-CD38 human antibody Daratumumab in the treatment of relapsed or refractory primary light chain amyloidosis: 2 cases report and literatures review.

VernacularTitle:抗CD38抗体Daratumumab治疗复发/难治性原发性轻链型淀粉样变二例报告并文献复习
Author: Su GAO ¹ ; Cong Li ZHANG ² ; Jian LI ² ; Han YAN ¹ ; Bo ZHANG ¹ ; Yu HU ¹ ; Chun Yan SUN ¹
Author Information

1. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
2. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Publication Type:Review
MeSH: Antibodies, Monoclonal; Humans; Immunoglobulin Light-chain Amyloidosis; Multiple Myeloma
From: Chinese Journal of Hematology 2019;40(4):336-338
CountryChina
Language:Chinese